本页面由Tiger Trade Technology Pte. Ltd.提供服务

梯瓦制药

41.32
+0.22000.54%
成交量:209.64万
成交额:8,641.85万
市值:481.38亿
市盈率:68.87
高:41.49
开:41.35
低:40.94
收:41.10
52周最高:42.02
52周最低:18.83
股本:11.65亿
流通股本:10.87亿
量比:1.02
换手率:0.19%
股息:- -
股息率:- -
每股收益(TTM):0.6000
每股收益(LYR):1.21
净资产收益率:9.69%
总资产收益率:5.13%
市净率:6.21
市盈率(LYR):34.15

数据加载中...

2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/01/28

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/11

重要事件披露

Form 8-K - Current report
2025/12/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/05

重要事件披露

Form 8-K - Current report
2025/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities